Every month, on behalf of greater than $600B in client hedge fund capital, PivotalPath tracks 3000+ institutionally-relevant hedge funds, spanning over $3T of assets.
Key Takeaways
Pivotal Point In Time: Beware the Ides of March! The end of Q1 witnessed a month where managers had to work hard to prove they could do more than just participate in risk-on markets. In many ways it wasn’t a fair test, as the month combined style rotation, macro uncertainty and a sharp deterioration in risk sentiment in one toxic tape.
The PivotalPath Hedge Fund Composite Index fell 2.2%, leaving industry performance at 1.0% YTD, as markets were hit by a mix of AI payback questions, private-credit nerves and then a full energy-and-inflation shock as the Iran conflict deepened.
By late month, the Nasdaq had fallen into correction territory, the S&P 500 was heading for its worst quarter in four years, and the Fed was lifting its inflation outlook, leaving managers to navigate a market with less help from broad beta and much more demand for selectivity, liquidity and risk control. With some managers predicting a quick snap back (as evidenced by the events of 15 April!) but others forecasting a longer-term malaise, the Ides suggest that the broader backdrop fits a view that 2026 will be a differentiated, supply-shock-driven market in which traditional diversification is weaker and dispersion matters more – a challenge, but also an opportunity for the most skillful funds.
- March was a tough test, with only 28% of funds positive in the month. The average gain among winners was 2.69%, while the average loss among decliners was 4.27%. This was definitely not a month where managers could sit still and let the markets do the work.
- Equity-heavy books bore the brunt of the damage. The weakest strategy returns in March came from the PivotalPath Equity Diversified Index which fell by 4.6%, its worst single month since a plunge of 7.5% during the Covid-era, when in March 2020 markets were forced to rapidly price in a halt to the real economy.
- In fact, the month was a great equity leveler with all sectors and strategies tainted by the confusion. From a geographic perspective Asia focused funds fared the worst – the PivotalPath Equity Diversified: Asia Long/Short Index plunged by 5.8%, as foreign investors exited and a number of managers upped their shorts on rising oil and stagflation fears, with crowded AI and semiconductor longs in Taiwan and South Korea suddenly turning from market leaders into a source of risk.
Hedge Fund Performance
Strategy Highlights: While most strategies remain positive YTD, March reversed early-2026 record gains as managers struggled with cross-sectional confusion and a distinct lack of safe havens.
- While equity strategies caught the headline flak, it’s also worth considering the trajectory of Global Macro players over a rough month, where the PivotalPath Discretionary Global Macro Index dropped by 2.4%, wiping away half of its 2026 gains.
- The fall was particularly pronounced in the PivotalPath Global Macro: Discretionary Index which dropped by 4.6% and the PivotalPath Global Macro: Multi-Manager Index which experienced a retreat of 5.7%.
- Discretionary Macro struggled as March delivered noise rather than a single tradable theme, with oil, inflation, rates and equities all pulling in awkward directions at once.
- Long US Treasury exposure likely hurt some managers, as the late-month energy shock pushed yields and inflation expectations higher just when duration was supposed to help.
- Quant specialists were a little better equipped to handle the noise, with the PivotalPath Global Macro:Quantitative Index up 0.3%, as March offered strong, tradeable cross-asset signals, especially in commodities, FX and relative rates, while punishing slower, more thesis-driven discretionary books.
- And while Quant Macro survived, Quant Equity thrived, with the PivotalPath Equity Quant Index up 1.9%, as this cohort took advantage of wild dispersion patterns.
Read the full report here by PivotalPath
